Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone
These qualitative findings can inform health systems of potential patient concerns to address when considering the transition from cotesting every 3 years to primary HPV testing every 5 years for cervical cancer screening.
Authors
- S. Goldberg
- Brian Hixon (ORCID: https://orcid.org/0000-0001-6825-7409)
- Larissa L. White (ORCID: https://orcid.org/0000-0001-9364-2704)
- Brian S. Mittman (ORCID: https://orcid.org/0000-0003-3589-9178)
- Chun Chao (ORCID: https://orcid.org/0000-0002-6072-4954)
- Erin Elizabeth Hahn (ORCID: https://orcid.org/0000-0002-8419-2331)
- Heather Spencer Feigelson (ORCID: https://orcid.org/0000-0001-6691-3740)
- Devansu Tewari
- Antonio Escobar (ORCID: https://orcid.org/0009-0009-9098-6953)
Institutions
- Kaiser Permanente (US)
- Colorado Permanente Medical Group (US)
- Kaiser Permanente Orange County Irvine Medical Center (US)
Publication Details
- Journal
- The Permanente Journal
- Published
- 2024-10-24
- DOI
- https://doi.org/10.7812/tpp/24.076
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39